StockData
Dogwood Therapeutics, Inc. logo

Dogwood Therapeutics, Inc. (DWTX) stock

DWTXNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 6/30
$1.03−0.03 (-2.36%)

Close on Nov 20, 2026Market cap $35.18MP/E –Yield –

Dogwood Therapeutics free cash flow

Free cash flow is cash from operations minus capital expenditures: the cash available for dividends, buybacks, debt repayment or acquisitions.

No free cash flow figures for Dogwood Therapeutics

Dogwood Therapeutics has not reported this figure in its SEC filings, or the share price needed to calculate it is not available yet.

More Dogwood Therapeutics figures

See a number that looks wrong?